Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress

Resveratrol, obesity and diabetes

(2010) Katarzyna Szkudelska et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet

(2010) M. T. Macarulla et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

Resveratrol and chemoprevention

(2009) Shyamal K. Goswami et al.   CANCER LETTERS

Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications

(2009) Elisa Fabbrini et al.   HEPATOLOGY

Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase

(2008) Jing SHANG et al.   ACTA PHARMACOLOGICA SINICA

Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters

(2008) Il Jin Cho et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

(2008) Leonor Rivera et al.   BIOCHEMICAL PHARMACOLOGY

Resveratrol inhibits nonalcoholic fatty liver disease in rats

(2008) Luis Bujanda et al.   BMC GASTROENTEROLOGY

Resveratrol supplementation worsen the dysregulation of genes involved in hepatic lipid homeostasis observed in hyperhomocysteinemic mice

(2008) Christophe Noll et al.   FOOD AND CHEMICAL TOXICOLOGY

Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet

(2008) Jiyun Ahn et al.   JOURNAL OF HEPATOLOGY